The efficacy and safety of apixaban: what has changed in 12 years of its use in real clinical practice?
This review examines the position of apixaban among other direct oral anticoagulants in patients with atrial fibrillation (AF) and venous thrombosis in randomized clinical trials and real clinical practice. Since the advent of apixaban, many studies of real clinical practice (RCP) and meta-analyses...
Saved in:
Main Author: | E. Р. Panchenko (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE
by: O. O. Shakhmatova, et al.
Published: (2017) -
Efficacy and safety of Apixaban for the prevention of thrombosis in arteriovenous grafts
by: Arash Hedayat, et al.
Published: (2024) -
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
by: Werth S, et al.
Published: (2012) -
Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020) -
Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer
by: E. P. Panchenko
Published: (2020)